Alzheimer's disease: A review concerning immune response and microischemia

R. L. Chorsky, F. Yaghmai, William D Hill, E. G. Stopa

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Alzheimer's disease (AD), as we think of it today, is the idiopathic progressive loss of cognitive function over a period of several years. The risk of late onset dementia increases significantly with each decade of life such that half of the population over the age of 80 is vulnerable to this disease (1). We know that proper functioning of the central nervous system is dependent on adequate blood flow to remove harmful metabolic products and supply nutrients such as glucose and oxygen to the brain. It has been suggested that cerebral hypoperfusion causes AD (2). Mean cerebral blood flow decreases with age and with sclerosis of cerebral blood vessels. Blood flow appears to increase in stimulated areas of the brain during different activities. However, there is a derangement of blood flow in disease states; this has been documented in the temporal lobes of AD patients, (3,4). English language journal articles located by a MEDLINE search (1960-1999) were reviewed with consideration to the hypothesis that Alzheimer's disease is an autoimmune disease initiated by low oxygen tension and microischemia. Inflammation is thought to be a known contributor to the pathology of AD (5,6). Recent reports support the concept of autoimmunity as a final common pathway of neuron death, particularly for cholinergic in Alzheimer's disease (6). A model of Alzheimer's disease is proposed and related research and treatment modalities are discussed.

Original languageEnglish (US)
Pages (from-to)124-127
Number of pages4
JournalMedical Hypotheses
Volume56
Issue number1
DOIs
StatePublished - Jan 1 2001

Fingerprint

Alzheimer Disease
Cerebrovascular Circulation
Oxygen
Tuberous Sclerosis
Brain
Temporal Lobe
Autoimmunity
MEDLINE
Cognition
Cholinergic Agents
Autoimmune Diseases
Blood Vessels
Dementia
Language
Central Nervous System
Pathology
Inflammation
Neurons
Glucose
Food

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Alzheimer's disease : A review concerning immune response and microischemia. / Chorsky, R. L.; Yaghmai, F.; Hill, William D; Stopa, E. G.

In: Medical Hypotheses, Vol. 56, No. 1, 01.01.2001, p. 124-127.

Research output: Contribution to journalArticle

Chorsky, RL, Yaghmai, F, Hill, WD & Stopa, EG 2001, 'Alzheimer's disease: A review concerning immune response and microischemia', Medical Hypotheses, vol. 56, no. 1, pp. 124-127. https://doi.org/10.1054/mehy.2000.1148
Chorsky, R. L. ; Yaghmai, F. ; Hill, William D ; Stopa, E. G. / Alzheimer's disease : A review concerning immune response and microischemia. In: Medical Hypotheses. 2001 ; Vol. 56, No. 1. pp. 124-127.
@article{097ebd8e02ef4e9487a6d72ffbd6517d,
title = "Alzheimer's disease: A review concerning immune response and microischemia",
abstract = "Alzheimer's disease (AD), as we think of it today, is the idiopathic progressive loss of cognitive function over a period of several years. The risk of late onset dementia increases significantly with each decade of life such that half of the population over the age of 80 is vulnerable to this disease (1). We know that proper functioning of the central nervous system is dependent on adequate blood flow to remove harmful metabolic products and supply nutrients such as glucose and oxygen to the brain. It has been suggested that cerebral hypoperfusion causes AD (2). Mean cerebral blood flow decreases with age and with sclerosis of cerebral blood vessels. Blood flow appears to increase in stimulated areas of the brain during different activities. However, there is a derangement of blood flow in disease states; this has been documented in the temporal lobes of AD patients, (3,4). English language journal articles located by a MEDLINE search (1960-1999) were reviewed with consideration to the hypothesis that Alzheimer's disease is an autoimmune disease initiated by low oxygen tension and microischemia. Inflammation is thought to be a known contributor to the pathology of AD (5,6). Recent reports support the concept of autoimmunity as a final common pathway of neuron death, particularly for cholinergic in Alzheimer's disease (6). A model of Alzheimer's disease is proposed and related research and treatment modalities are discussed.",
author = "Chorsky, {R. L.} and F. Yaghmai and Hill, {William D} and Stopa, {E. G.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1054/mehy.2000.1148",
language = "English (US)",
volume = "56",
pages = "124--127",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Alzheimer's disease

T2 - A review concerning immune response and microischemia

AU - Chorsky, R. L.

AU - Yaghmai, F.

AU - Hill, William D

AU - Stopa, E. G.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Alzheimer's disease (AD), as we think of it today, is the idiopathic progressive loss of cognitive function over a period of several years. The risk of late onset dementia increases significantly with each decade of life such that half of the population over the age of 80 is vulnerable to this disease (1). We know that proper functioning of the central nervous system is dependent on adequate blood flow to remove harmful metabolic products and supply nutrients such as glucose and oxygen to the brain. It has been suggested that cerebral hypoperfusion causes AD (2). Mean cerebral blood flow decreases with age and with sclerosis of cerebral blood vessels. Blood flow appears to increase in stimulated areas of the brain during different activities. However, there is a derangement of blood flow in disease states; this has been documented in the temporal lobes of AD patients, (3,4). English language journal articles located by a MEDLINE search (1960-1999) were reviewed with consideration to the hypothesis that Alzheimer's disease is an autoimmune disease initiated by low oxygen tension and microischemia. Inflammation is thought to be a known contributor to the pathology of AD (5,6). Recent reports support the concept of autoimmunity as a final common pathway of neuron death, particularly for cholinergic in Alzheimer's disease (6). A model of Alzheimer's disease is proposed and related research and treatment modalities are discussed.

AB - Alzheimer's disease (AD), as we think of it today, is the idiopathic progressive loss of cognitive function over a period of several years. The risk of late onset dementia increases significantly with each decade of life such that half of the population over the age of 80 is vulnerable to this disease (1). We know that proper functioning of the central nervous system is dependent on adequate blood flow to remove harmful metabolic products and supply nutrients such as glucose and oxygen to the brain. It has been suggested that cerebral hypoperfusion causes AD (2). Mean cerebral blood flow decreases with age and with sclerosis of cerebral blood vessels. Blood flow appears to increase in stimulated areas of the brain during different activities. However, there is a derangement of blood flow in disease states; this has been documented in the temporal lobes of AD patients, (3,4). English language journal articles located by a MEDLINE search (1960-1999) were reviewed with consideration to the hypothesis that Alzheimer's disease is an autoimmune disease initiated by low oxygen tension and microischemia. Inflammation is thought to be a known contributor to the pathology of AD (5,6). Recent reports support the concept of autoimmunity as a final common pathway of neuron death, particularly for cholinergic in Alzheimer's disease (6). A model of Alzheimer's disease is proposed and related research and treatment modalities are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0035174943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035174943&partnerID=8YFLogxK

U2 - 10.1054/mehy.2000.1148

DO - 10.1054/mehy.2000.1148

M3 - Article

C2 - 11133269

AN - SCOPUS:0035174943

VL - 56

SP - 124

EP - 127

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 1

ER -